Benzinga | Nov 3, 2021 09:15AM EDT

Autolus Therapeutics Q3 EPS $(0.47) Beats $(0.51) Estimate

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.51) by 7.84 percent. This is a 34.72 percent increase over losses of $(0.72) per share from the same period last year.